RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (MARKET WIRE) -- May 30, 2007 -- Adherex Technologies Inc. (TSX: AHX)(AMEX: ADH) a biopharmaceutical company with a broad portfolio of oncology products under development, today announced that the following three abstracts will be presented at the 2007 American Society of Clinical Oncology (ASCO) annual meeting in Chicago on Sunday, June 3, 2007 from 8:00 AM to 12:00 PM:
